Rutgers Cancer Institute(@RutgersCancer) 's Twitter Profileg
Rutgers Cancer Institute

@RutgersCancer

Rutgers Cancer Institute is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.

ID:2802993134

linkhttp://cinj.org/ calendar_today11-09-2014 04:16:49

7,6K Tweets

4,0K Followers

1,3K Following

ECOG-ACRIN Cancer Research Group(@eaonc) 's Twitter Profile Photo

EA9152, led by Neil Palmisiano, MD of Rutgers Cancer Institute, is investigating the safety & efficacy of venetoclax, a BCL-2 inhibitor, in combination with vincristine sulfate in the relapsed or refractory population. More: bit.ly/EA9152 cc: Acute Leukemia Advocates Network (ALAN)

#Clinicaltrial EA9152, led by Neil Palmisiano, MD of @RutgersCancer, is investigating the safety & efficacy of venetoclax, a BCL-2 inhibitor, in combination with vincristine sulfate in the relapsed or refractory #ALL population. More: bit.ly/EA9152 #leusm cc: @AcuteLeuk
account_circle
Vignesh Packiam, MD(@VigneshPackiam) 's Twitter Profile Photo

Always fun to chat with Sam S. Chang MD, MBA!

More data supporting non-risk adapted use of Gem/Doce - consistent efficacy in a variety of stages and grades of NMIBC

Raises question of utility of maintenance especially in low grade disease

Saum Ghodoussipour Rutgers Cancer Institute Rutgers RWJ Urology Ian McElree

account_circle
NCI Office of Cancer Survivorship(@NCICancerSurv) 's Twitter Profile Photo

In today’s OCS New Investigator’s Series webinar, Dr. Katie Devine of Rutgers RWJMedSchool & Rutgers Cancer Institute shares opportunities for collaboration, such as joining professional organizations, attending conferences & trainings, & scheduling meetings with researchers & other professionals.

In today’s OCS New Investigator’s Series webinar, Dr. Katie Devine of @RWJMS & @RutgersCancer shares opportunities for collaboration, such as joining professional organizations, attending conferences & trainings, & scheduling meetings with researchers & other professionals.
account_circle
Rutgers Cancer Institute(@RutgersCancer) 's Twitter Profile Photo


Dr. Tengteng Wang Tengteng Wang has received more than $700k from National Cancer Institute for her research examining the association between reproductive factors, gut microbiome & benign breast disease (BBD). cinj.org/exploring-repr…
Rutgers Cancer Institute RWJBarnabas

#NationalCancerResearchMonth Dr. Tengteng Wang @TengtengW_EPI has received more than $700k from @theNCI for her research examining the association between reproductive factors, gut microbiome & benign breast disease (BBD). cinj.org/exploring-repr… @RutgersCancer @RWJBarnabas
account_circle
Targeted Oncology(@TargetedOnc) 's Twitter Profile Photo

In our most recent episode of Targeted Talks, M. Michele Blackwood, MD, FACS, discusses treatments for patients with breast cancer and how personalized medicine with genomic testing is changing the field. | Rutgers Cancer Institute RWJBarnabas

targetedonc.com/view/the-futur…

account_circle
Matthew Matasar, MD(@DrMatasar) 's Twitter Profile Photo

My secret to being a good doc is working with great nurses and APPs. So a special shout out to the Heme Malignancy nurses that *dominated* our nursing awards! Kim Laino (who’s been w me through it all!), Kira Lynn Voitle, Kathy Kafka, Joyce Herrera - so proud! Rutgers Cancer Institute

account_circle
NCI Office of Cancer Survivorship(@NCICancerSurv) 's Twitter Profile Photo

Join us tomorrow for this OCS New Investigators Series webinar. Dr. Katie Devine of Rutgers RWJMedSchool and Rutgers Cancer Institute will present Building Partnerships to Sustain Your Program of Research cancercontrol.cancer.gov/ocs/about/even…

Join us tomorrow for this OCS New Investigators Series webinar. Dr. Katie Devine of @RWJMS and @RutgersCancer will present Building Partnerships to Sustain Your Program of Research cancercontrol.cancer.gov/ocs/about/even… #survonc #cancersurvivorship
account_circle
Rutgers Cancer Institute(@RutgersCancer) 's Twitter Profile Photo

Rutgers Cancer Institute: “A Phase 1b Study Evaluating the Safety & Efficacy of First-Line Tarlatamab in Combination With Carboplatin, Etoposide, & PD-L1 Inhibitor in Subjects with Extensive Stage Small Cell Lung Cancer.”
RWJBarnabas Missak Haigentz

cinj.org/clinical-trial…

@RutgersCancer: “A Phase 1b Study Evaluating the Safety & Efficacy of First-Line Tarlatamab in Combination With Carboplatin, Etoposide, & PD-L1 Inhibitor in Subjects with Extensive Stage Small Cell Lung Cancer.” @RWJBarnabas @DrHaigentz #LCSM cinj.org/clinical-trial…
account_circle
Rutgers Cancer Institute(@RutgersCancer) 's Twitter Profile Photo

Join us for the Survivorship Wellness Series! RWJBarnabas's Karen Connelly, RD, CSO will lead 'Proper Nutrition' on 5/16. The series is open to cancer survivors associated with Rutgers Cancer Institute programs & their loved ones. cinj.org/patient-care/s…

Join us for the Survivorship Wellness Series! @RWJBarnabas's Karen Connelly, RD, CSO will lead 'Proper Nutrition' on 5/16. The series is open to cancer survivors associated with @RutgersCancer programs & their loved ones. cinj.org/patient-care/s…
account_circle
NCI Office of Cancer Survivorship(@NCICancerSurv) 's Twitter Profile Photo

Join NCI Office of Cancer Survivorship on May 14 at 2 pm ET for this New Investigators Series webinar. Dr. Katie Devine of Rutgers RWJMedSchool and RutgersCancerInstNJ will present Building Partnerships to Sustain Your Program of Research cancercontrol.cancer.gov/ocs/about/even…

Join @NCICancerSurv on May 14 at 2 pm ET for this New Investigators Series webinar. Dr. Katie Devine of @RWJMS and @RutgersCancer will present Building Partnerships to Sustain Your Program of Research cancercontrol.cancer.gov/ocs/about/even… #SurvOnc #CancerSurvivorship
account_circle